{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:45:08Z","timestamp":1791229508517,"version":"4.1.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3679,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2005.06710.x","type":"journal-article","created":{"date-parts":[[2005,8,20]],"date-time":"2005-08-20T02:12:18Z","timestamp":1124503938000},"page":"650-652","source":"Crossref","is-referenced-by-count":22,"title":["Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin"],"prefix":"10.1093","volume":"153","author":[{"given":"B.","family":"Shergill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Orteu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.A.","family":"Rustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,8,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/mjd.2001.111630","article-title":"Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema","volume":"44","author":"Ronglioletti","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0190-9622(93)70021-K","article-title":"The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis)","volume":"28","author":"Webster","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00005792-200109000-00005","article-title":"The neurologic complications of scleromyxedema","volume":"80","author":"Berger","year":"2001","journal-title":"Medicine"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","article-title":"Scleromyxedema","volume":"33","author":"Dinneen","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1067\/mjd.2000.104001","article-title":"Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg)","volume":"43","author":"Lister","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00277-004-0895-2","article-title":"Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature","volume":"83","author":"Hefer","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/WNL.46.6.1778","article-title":"Fever, convulsions and coma in scleromyxedema: a \u2018dermato-neuro syndrome\u2019","volume":"46","author":"River","year":"1996","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB9|cit9","first-page":"1071","article-title":"Complete remission of scleromyxedema following autologous stem cell transplantation","volume":"137","author":"Feasel","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.53.5.1138","article-title":"Encephalopathy in scleromyxedema","volume":"53","author":"Johkura","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0190-9622(00)90274-3","article-title":"Scleromyxedema with dermato-neuro syndrome","volume":"42","author":"Gonzalez","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB12|cit12","first-page":"471","article-title":"Acute cerebral symptomatology, a rare presentation of scleromyxedema","volume":"39","author":"Ochitill","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2340\/00015555607779","article-title":"Two cases of scleromyxedema","volume":"60","author":"Jepsen","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ja01207a034","article-title":"Preparation and properties of serum and plasma proteins: a system for the separation into fractions of the protein and lipoprotein components of biological fluids","volume":"68","author":"Cohn","year":"1946","journal-title":"J Am Chem Soc"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2005.06710.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jnnp.57.Suppl.2","article-title":"Requirements for safety and quality of intravenous immunoglobulin G preparations","volume":"57","author":"Rutter","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1365-2133.2005.06710.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archderm.140.3.277","article-title":"Thalidomide as a potential treatment for scleromyxedema","volume":"140","author":"Caradonna","year":"2004","journal-title":"Arch Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.06710.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2005.06710.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T07:36:01Z","timestamp":1683185761000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/153\/3\/650\/6636882"}},"subtitle":["IVIg for dementia in scleromyxoedema"],"short-title":[],"issued":{"date-parts":[[2005,8,5]]},"references-count":16,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06710.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8,5]]}}}